Cargando…
Current Situation and Prospect of Adoptive Cellular Immunotherapy for Malignancies
Adoptive cell immunotherapy (ACT) is an innovative promising treatment for tumors. ACT is characterized by the infusion of active anti-tumor immune cells (specific and non-specific) into patients to kill tumor cells either directly or indirectly by stimulating the body's immune system. The pati...
Autores principales: | Zhao, Dong, Zhu, Dantong, Cai, Fei, Jiang, Mingzhe, Liu, Xuefei, Li, Tingting, Zheng, Zhendong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693217/ https://www.ncbi.nlm.nih.gov/pubmed/38037341 http://dx.doi.org/10.1177/15330338231204198 |
Ejemplares similares
-
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
por: Heiss, Markus M, et al.
Publicado: (2010) -
CT-128 Simple Prognostic Markers in Patients With Hematological Malignancies and COVID-19 Infection: Single-Center Experience
por: Rakha, Nahed Moawad, et al.
Publicado: (2022) -
Poster: CT-128 Simple Prognostic Markers in Patients With Hematological Malignancies and COVID-19 Infection: Single-Center Experience
por: Rakha, Nahed Moawad, et al.
Publicado: (2022) -
Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites
por: Ott, Marion G, et al.
Publicado: (2012) -
Cellular and gene therapy
por: Padua, Rose Ann
Publicado: (2019)